Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients

Lucia De Monte(Vita-Salute San Raffaele University), Sonja M. Wörmann(TUM Klinikum), Emanuela Brunetto(Vita-Salute San Raffaele University), Silvia Heltai(Vita-Salute San Raffaele University), Gilda Magliacane(Vita-Salute San Raffaele University), Michele Reni(Vita-Salute San Raffaele University), Anna Maria Paganoni(Politecnico di Milano), Helios Recalde(Ospedale San Paolo), Anna Mondino(Vita-Salute San Raffaele University), Massimo Falconi(Vita-Salute San Raffaele University), Francesca Aleotti(Vita-Salute San Raffaele University), Gianpaolo Balzano(Vita-Salute San Raffaele University), Hana Algül(TUM Klinikum), Claudio Doglioni(Vita-Salute San Raffaele University), Maria Pia Protti(Vita-Salute San Raffaele University)
Cancer Research
February 13, 2016
Cited by 156Open Access
Full Text

Abstract

In pancreatic ductal adenocarcinomas (PDAC), lymphoid infiltrates, comprised mainly of Th2 cells, predict a poor survival outcome in patients. IL4 signaling has been suggested to stabilize the Th2 phenotype in this setting, but the cellular source of IL4 in PDAC is unclear. Here, we show that basophils expressing IL4 are enriched in tumor-draining lymph nodes (TDLN) of PDAC patients. Basophils present in TDLNs correlated significantly with the Th2/Th1 cell ratio in tumors, where they served as an independent prognostic biomarker of patient survival after surgery. Investigations in mouse models of pancreatic cancer confirmed a functional role for basophils during tumor progression. The recruitment of basophils into TDLN relied partly upon the release of chemokine CCL7/MCP3 by "alternatively activated" monocytes, whereas basophil activation was induced by T-cell-derived IL3. Our results show how basophils recruited and activated in TDLNs under the influence of the tumor microenvironment regulate tumor-promoting Th2 inflammation in PDAC, helping in illuminating a key element of the immune milieu of pancreatic cancer. Cancer Res; 76(7); 1792-803. ©2016 AACR.


Related Papers

No related papers found

Powered by citation graph analysis